Celularity (CELUW) Amortization of Goodwill (2022 - 2023)

Celularity (CELUW) reported Amortization of Goodwill of $82.7 million for Q3 2023, up 179.13% quarter-over-quarter from $29.6 million in Q1 2023.

Celularity (CELUW) Amortization of Goodwill (2022 - 2023) Analysis & Trends

Celularity (CELUW) has 2 years of Amortization of Goodwill data on file, last reported at $82.7 million in Q3 2023.

Amortization of Goodwill for Q3 2023 came in at $82.7 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was $82.7 million (up 148.82% YoY), and the FY2023 annual result was $112.3 million, up 3012.11% from the prior year.
Amortization of Goodwill grew to $82.7 million in Q3 2023 per CELUW's latest filing, from $29.6 million in the prior quarter.
Over five years, Amortization of Goodwill peaked at $82.7 million in Q3 2023 and troughed at $3.6 million in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Celularity	-	-	-3.27 Mn

Download Data